Health
Growing Value of Stem Cells in Medicine to Create a US$2,4 Billion Opportunity for Induced Pluripotent Stem Cell ((iPSC) – GlobeNewswire
Growing Value of Stem Cells in Medicine to Create a US$2. 4 Billion Opportunity for Induced Pluripotent Stem Cell ((iPSC).
New York, Nov. 25, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Induced Pluripotent Stem Cell (iPSC) Industry” – https://www.reportlinker.com/p05798831/?utm_source=GNW4 billion by the year 2027, trailing a post COVID-19 CAGR of 6.6%, over the analysis period 2020 through 2027. Stem cells are undifferentiated cells that hold the capability to divide, and differentiate into specialized cells in the body. Stem cells act as repair system and replenish adult tissues,…
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business16 hours agoDicker Data rides the AI trend to double digit growth
-
Business19 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy